{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T01:52:51Z","timestamp":1787536371527,"version":"build-2736575974"},"reference-count":79,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2023]]},"DOI":"10.3960\/jslrt.23012","type":"journal-article","created":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T22:39:54Z","timestamp":1693175994000},"page":"143-151","source":"Crossref","is-referenced-by-count":6,"title":["Follicular lymphoma microenvironment: insights provided by                    single-cell analysis"],"prefix":"10.3960","volume":"63","author":[{"given":"Yoshiaki","family":"Abe","sequence":"first","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of                            Tsukuba, Tsukuba, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Swerdlow SH, Campo E, Harris NL, <i>et                        al.<\/i> (eds). WHO Classification of Tumours of Haematopoietic and                    Lymphoid Tissues. 4th ed., Revised ed, Lyon, International Agency for Research                    on Cancer. 2017; pp. 190-198."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Horning                            SJ,                                Rosenberg                            SA. The natural                    history of initially untreated low-grade non-Hodgkin\u2019s lymphomas. N Engl J Med.                    1984; 311: 1471-1475.","DOI":"10.1056\/NEJM198412063112303"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Pastore                            A,                                Jurinovic                            V,                                Kridel                            R                    <i>et al.<\/i> Integration of gene mutations in risk prognostication                    for patients receiving first-line immunochemotherapy for follicular lymphoma: a                    retrospective analysis of a prospective clinical trial and validation in a                    population-based registry. Lancet Oncol. 2015; 16: 1111-1122.","DOI":"10.1016\/S1470-2045(15)00169-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Jurinovic                            V,                                Kridel                            R,                                Staiger                            AM                    <i>et al.<\/i> Clinicogenetic risk models predict early progression of                    follicular lymphoma after first-line immunochemotherapy. Blood. 2016; 128:                    1112-1120.","DOI":"10.1182\/blood-2016-05-717355"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Casulo                            C,                                Byrtek                            M,                                Dawson                            KL                    <i>et al.<\/i> Early Relapse of Follicular Lymphoma After Rituximab                    Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients                    at High Risk for Death: An Analysis From the National LymphoCare Study. J Clin                    Oncol. 2015; 33: 2516-2522.","DOI":"10.1200\/JCO.2014.59.7534"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Maurer                            MJ,                                Bachy                            E,                                Ghesqui\u00e8res                            H                    <i>et al.<\/i> Early event status informs subsequent outcome in newly                    diagnosed follicular lymphoma. Am J Hematol. 2016; 91:                    1096-1101.","DOI":"10.1002\/ajh.24492"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Sarkozy                            C,                                Maurer                            MJ,                                Link                            BK                    <i>et al.<\/i> Cause of Death in Follicular Lymphoma in the First                    Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts. J Clin                    Oncol. 2019; 37: 144-152.","DOI":"10.1200\/JCO.18.00400"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Carbone                            A,                                Roulland                            S,                                Gloghini                            A                    <i>et al.<\/i> Follicular lymphoma. Nat Rev Dis Primers. 2019; 5:                    83.","DOI":"10.1038\/s41572-019-0132-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Am\u00e9-Thomas                            P, Le                                Priol                            J,                                Yssel                            H                    <i>et al.<\/i> Characterization of intratumoral follicular helper T                    cells in follicular lymphoma: role in the survival of malignant B cells.                    Leukemia. 2012; 26: 1053-1063.","DOI":"10.1038\/leu.2011.301"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Rawal                            S,                                Chu                            F,                                Zhang                            M                    <i>et al.<\/i> Cross talk between follicular Th cells and tumor cells                    in human follicular lymphoma promotes immune evasion in the tumor                    microenvironment. J Immunol. 2013; 190: 6681-6693.","DOI":"10.4049\/jimmunol.1201363"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 B\u00e9guelin                            W,                                Teater                            M,                                Meydan                            C                    <i>et al.<\/i> Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by                    Reprogramming the Immune Response. Cancer Cell. 2020; 37:                    655-673.e11.","DOI":"10.1016\/j.ccell.2020.04.004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Tobin                            JWD,                                Keane                            C,                                Gunawardana                            J                    <i>et al.<\/i> Progression of Disease Within 24 Months in Follicular                    Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration. J Clin                    Oncol. 2019; 37: 3300-3309.","DOI":"10.1200\/JCO.18.02365"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Carreras                            J,                                Lopez-Guillermo                            A,                                Fox                            BC                    <i>et al.<\/i> High numbers of tumor-infiltrating FOXP3-positive                    regulatory T cells are associated with improved overall survival in follicular                    lymphoma. Blood. 2006; 108: 2957-2964.","DOI":"10.1182\/blood-2006-04-018218"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Farinha                            P,                                Al-Tourah                            A,                                Gill                            K                    <i>et al.<\/i> The architectural pattern of FOXP3-positive T cells in                    follicular lymphoma is an independent predictor of survival and histologic                    transformation. Blood. 2010; 115: 289-295.","DOI":"10.1182\/blood-2009-07-235598"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Baslan                            T,                                Hicks                            J. Unravelling                    biology and shifting paradigms in cancer with single-cell sequencing. Nat Rev                    Cancer. 2017; 17: 557-569.","DOI":"10.1038\/nrc.2017.58"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Davis-Marcisak                            EF,                                Deshpande                            A,                                Stein-O\u2019Brien                            GL                    <i>et al.<\/i> From bench to bedside: Single-cell analysis for cancer                    immunotherapy. Cancer Cell. 2021; 39: 1062-1080.","DOI":"10.1016\/j.ccell.2021.07.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Lavie                            D,                                Ben-Shmuel                            A,                                Erez                            N,                                Scherz-Shouval                            R.                    Cancer-associated fibroblasts in the single-cell era. Nat Cancer. 2022; 3:                    793-807.","DOI":"10.1038\/s43018-022-00411-z"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Papalexi                            E,                                Satija                            R. Single-cell                    RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol. 2018; 18:                    35-45.","DOI":"10.1038\/nri.2017.76"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Holmes                            AB,                                Corinaldesi                            C,                                Shen                            Q                    <i>et al.<\/i> Single-cell analysis of germinal-center B cells informs                    on lymphoma cell of origin and outcome. J Exp Med. 2020; 217:                        e20200483.","DOI":"10.1084\/jem.20200483"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Steen                            CB,                                Luca                            BA,                                Esfahani                            MS                    <i>et al.<\/i> The landscape of tumor cell states and ecosystems in                    diffuse large B cell lymphoma. Cancer Cell. 2021; 39:                    1422-1437.e10.","DOI":"10.1016\/j.ccell.2021.08.011"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Rindler                            K,                                Jonak                            C,                                Alkon                            N                    <i>et al.<\/i> Single-cell RNA sequencing reveals markers of disease                    progression in primary cutaneous T-cell lymphoma. Mol Cancer. 2021; 20:                    124.","DOI":"10.1186\/s12943-021-01419-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Aoki                            T,                                Chong                            LC,                                Takata                            K                    <i>et al.<\/i> Single-Cell Transcriptome Analysis Reveals                    Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin                    Lymphoma. Cancer Discov. 2020; 10: 406-421.","DOI":"10.1158\/2159-8290.CD-19-0680"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Song                            X,                                Chang                            S,                                Seminario-Vidal                            L                    <i>et al.<\/i> Genomic and Single-Cell Landscape Reveals Novel Drivers                    and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma. Cancer                    Discov. 2022; 12: 1294-1313.","DOI":"10.1158\/2159-8290.CD-21-1207"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Milpied                            P,                                Cervera-Marzal                            I,                                Mollichella                            ML                    <i>et al.<\/i> Human germinal center transcriptional programs are                    de-synchronized in B cell lymphoma. Nat Immunol. 2018; 19:                    1013-1024.","DOI":"10.1038\/s41590-018-0181-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Andor                            N,                                Simonds                            EF,                                Czerwinski                            DK                    <i>et al.<\/i> Single-cell RNA-Seq of follicular lymphoma reveals                    malignant B-cell types and coexpression of T-cell immune checkpoints. Blood.                    2019; 133: 1119-1129.","DOI":"10.1182\/blood-2018-08-862292"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Roider                            T,                                Seufert                            J,                                Uvarovskii                            A                    <i>et al.<\/i> Dissecting intratumour heterogeneity of nodal B-cell                    lymphomas at the transcriptional, genetic and drug-response levels. Nat Cell                    Biol. 2020; 22: 896-906.","DOI":"10.1038\/s41556-020-0532-x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Haebe                            S,                                Shree                            T,                                Sathe                            A                    <i>et al.<\/i> Single-cell analysis can define distinct evolution of                    tumor sites in follicular lymphoma. Blood. 2021; 137:                    2869-2880.","DOI":"10.1182\/blood.2020009855"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Han                            G,                                Deng                            Q,                                Marques-Piubelli                            ML                    <i>et al.<\/i> Follicular Lymphoma Microenvironment Characteristics                    Associated with Tumor Cell Mutations and MHC Class II Expression. Blood Cancer                    Discov. 2022; 3: 428-443.","DOI":"10.1158\/2643-3230.BCD-21-0075"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Wang                            X,                                Nissen                            M,                                Gracias                            D                    <i>et al.<\/i> Single-cell profiling reveals a memory B cell-like                    subtype of follicular lymphoma with increased transformation risk. Nat Commun.                    2022; 13: 6772.","DOI":"10.1038\/s41467-022-34408-0"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Szabo                            PA,                                Levitin                            HM,                                Miron                            M                    <i>et al.<\/i> Single-cell transcriptomics of human T cells reveals                    tissue and activation signatures in health and disease. Nat Commun. 2019; 10:                    4706.","DOI":"10.1038\/s41467-019-12464-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Zheng                            L,                                Qin                            S,                                Si                            W                    <i>et al.<\/i> Pan-cancer single-cell landscape of tumor-infiltrating T                    cells. Science. 2021; 374:                    abe6474.","DOI":"10.1126\/science.abe6474"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Fazilleau                            N,                                Mark                            L,                                McHeyzer-Williams                            LJ,                                McHeyzer-Williams                            MG. Follicular                    helper T cells: lineage and location. Immunity. 2009; 30:                    324-335.","DOI":"10.1016\/j.immuni.2009.03.003"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Godfrey                            DI,                                MacDonald                            HR,                                Kronenberg                            M,                                Smyth                            MJ, Van                                Kaer                            L. NKT cells:                    what\u2019s in a name? Nat Rev Immunol. 2004; 4: 231-237.","DOI":"10.1038\/nri1309"},{"key":"34","unstructured":"34 Carbone                            A,                                Gloghini                            A,                                Gruss                            HJ,                                Pinto                            A. CD40 ligand                    is constitutively expressed in a subset of T cell lymphomas and on the                    microenvironmental reactive T cells of follicular lymphomas and Hodgkin\u2019s                    disease. Am J Pathol. 1995; 147: 912-922."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Pandey                            S,                                Mourcin                            F,                                Marchand                            T                    <i>et al.<\/i> IL-4\/CXCL12 loop is a key regulator of lymphoid stroma                    function in follicular lymphoma. Blood. 2017; 129: 2507-2518.","DOI":"10.1182\/blood-2016-08-737239"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Am\u00e9-Thomas                            P,                                Hoeller                            S,                                Artchounin                            C                    <i>et al.<\/i> CD10 delineates a subset of human IL-4 producing                    follicular helper T cells involved in the survival of follicular lymphoma B                    cells. Blood. 2015; 125: 2381-2385.","DOI":"10.1182\/blood-2015-02-625152"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Townsend                            W,                                Pasikowska                            M,                                Yallop                            D                    <i>et al.<\/i> The architecture of neoplastic follicles in follicular                    lymphoma; analysis of the relationship between the tumor and follicular helper T                    cells. Haematologica. 2020; 105: 1593-1603.","DOI":"10.3324\/haematol.2019.220160"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Bunse                            M,                                Pfeilschifter                            J,                                Bluhm                            J                    <i>et al.<\/i> CXCR5 CAR-T cells simultaneously target B cell                    non-Hodgkin\u2019s lymphoma and tumor-supportive follicular T helper cells. Nat                    Commun. 2021; 12: 240.","DOI":"10.1038\/s41467-020-20488-3"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Chu                            F,                                Li                            HS,                                Liu                            X                    <i>et al.<\/i> CXCR5+CD8+ T cells are a distinct functional subset with                    an antitumor activity. Leukemia. 2019; 33: 2640-2653.","DOI":"10.1038\/s41375-019-0464-2"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Tzankov                            A,                                Meier                            C,                                Hirschmann                            P                    <i>et al.<\/i> Correlation of high numbers of intratumoral FOXP3+                    regulatory T cells with improved survival in germinal center-like diffuse large                    B-cell lymphoma, follicular lymphoma and classical Hodgkin\u2019s lymphoma.                    Haematologica. 2008; 93: 193-200.","DOI":"10.3324\/haematol.11702"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Coutinho                            R,                                Clear                            AJ,                                Mazzola                            E                    <i>et al.<\/i> Revisiting the immune microenvironment of diffuse large                    B-cell lymphoma using a tissue microarray and immunohistochemistry: robust                    semi-automated analysis reveals CD3 and FoxP3 as potential predictors of                    response to R-CHOP. Haematologica. 2015; 100: 363-369.","DOI":"10.3324\/haematol.2014.110189"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Nakayama                            S,                                Yokote                            T,                                Akioka                            T                    <i>et al.<\/i> Infiltration of effector regulatory T cells predicts                    poor prognosis of diffuse large B-cell lymphoma, not otherwise specified. Blood                    Adv. 2017; 1: 486-493.","DOI":"10.1182\/bloodadvances.2016000885"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Bates                            GJ,                                Fox                            SB,                                Han                            C                    <i>et al.<\/i> Quantification of regulatory T cells enables the                    identification of high-risk breast cancer patients and those at risk of late                    relapse. J Clin Oncol. 2006; 24: 5373-5380.","DOI":"10.1200\/JCO.2006.05.9584"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Salama                            P,                                Phillips                            M,                                Grieu                            F                    <i>et al.<\/i> Tumor-infiltrating FOXP3+ T regulatory cells show strong                    prognostic significance in colorectal cancer. J Clin Oncol. 2009; 27:                    186-192.","DOI":"10.1200\/JCO.2008.18.7229"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Saito                            T,                                Nishikawa                            H,                                Wada                            H                    <i>et al.<\/i> Two FOXP3 (+) CD4 (+) T cell subpopulations distinctly                    control the prognosis of colorectal cancers. Nat Med. 2016; 22:                    679-684.","DOI":"10.1038\/nm.4086"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Chung                            Y,                                Tanaka                            S,                                Chu                            F                    <i>et al.<\/i> Follicular regulatory T cells expressing Foxp3 and Bcl-6                    suppress germinal center reactions. Nat Med. 2011; 17: 983-988.","DOI":"10.1038\/nm.2426"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Linterman                            MA,                                Pierson                            W,                                Lee                            SK                    <i>et al.<\/i> Foxp3+ follicular regulatory T cells control the                    germinal center response. Nat Med. 2011; 17: 975-982.","DOI":"10.1038\/nm.2425"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Wollenberg                            I,                                Agua-Doce                            A,                                Hern\u00e1ndez                            A                    <i>et al.<\/i> Regulation of the germinal center reaction by Foxp3+                    follicular regulatory T cells. J Immunol. 2011; 187: 4553-4560.","DOI":"10.4049\/jimmunol.1101328"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Nedelkovska                            H,                                Rosenberg                            AF,                                Hilchey                            SP                    <i>et al.<\/i> Follicular Lymphoma Tregs Have a Distinct Transcription                    Profile Impacting Their Migration and Retention in the Malignant Lymph Node.                    PLoS One. 2016; 11: e0155347.","DOI":"10.1371\/journal.pone.0155347"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Le                            KS,                                Thibult                            ML,                                Just-Landi                            S                    <i>et al.<\/i> Follicular B Lymphomas Generate Regulatory T Cells via                    the ICOS\/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS\/ICOSL                    Therapy. Cancer Res. 2016; 76: 4648-4660.","DOI":"10.1158\/0008-5472.CAN-15-0589"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Xie                            MM,                                Dent                            AL. Unexpected                    Help: Follicular Regulatory T Cells in the Germinal Center. Front Immunol. 2018;                    9: 1536.","DOI":"10.3389\/fimmu.2018.01536"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Melnick                            AM. Tee-ing up a                    New Follicular Lymphoma Classification System. Blood Cancer Discov. 2022; 3:                    374-377.","DOI":"10.1158\/2643-3230.BCD-22-0090"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Hasegawa                            T,                                Oka                            T,                                Son                            HG                    <i>et al.<\/i> Cytotoxic CD4+ T cells eliminate senescent cells by                    targeting cytomegalovirus antigen. Cell. 2023; 186:                    1417-1431.e20.","DOI":"10.1016\/j.cell.2023.02.033"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Guilloton                            F,                                Caron                            G,                                M\u00e9nard                            C                    <i>et al.<\/i> Mesenchymal stromal cells orchestrate follicular                    lymphoma cell niche through the CCL2-dependent recruitment and polarization of                    monocytes. Blood. 2012; 119: 2556-2567.","DOI":"10.1182\/blood-2011-08-370908"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Wilcox                            RA,                                Ristow                            K,                                Habermann                            TM                    <i>et al.<\/i> The absolute monocyte count is associated with overall                    survival in patients newly diagnosed with follicular lymphoma. Leuk Lymphoma.                    2012; 53: 575-580.","DOI":"10.3109\/10428194.2011.637211"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Watanabe                            R,                                Tomita                            N,                                Kishimoto                            K                    <i>et al.<\/i> Absolute monocyte count in follicular lymphoma patients                    treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and                    prednisone. Leuk Res. 2013; 37: 1208-1212.","DOI":"10.1016\/j.leukres.2013.07.015"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Mantovani                            A,                                Sica                            A. Macrophages,                    innate immunity and cancer: balance, tolerance, and diversity. Curr Opin                    Immunol. 2010; 22: 231-237.","DOI":"10.1016\/j.coi.2010.01.009"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Farinha                            P,                                Masoudi                            H,                                Skinnider                            BF                    <i>et al.<\/i> Analysis of multiple biomarkers shows that                    lymphoma-associated macrophage (LAM) content is an independent predictor of                    survival in follicular lymphoma (FL). Blood. 2005; 106:                    2169-2174.","DOI":"10.1182\/blood-2005-04-1565"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Taskinen                            M,                                Karjalainen-Lindsberg                            ML,                                Nyman                            H,                                Eerola                            LM,                                Lepp\u00e4                            S. A high                    tumor-associated macrophage content predicts favorable outcome in follicular                    lymphoma patients treated with rituximab and                    cyclophosphamide-doxorubicin-vincristine-prednisone. Clin Cancer Res. 2007; 13:                    5784-5789.","DOI":"10.1158\/1078-0432.CCR-07-0778"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Canioni                            D,                                Salles                            G,                                Mounier                            N                    <i>et al.<\/i> High numbers of tumor-associated macrophages have an                    adverse prognostic value that can be circumvented by rituximab in patients with                    follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol.                    2008; 26: 440-446.","DOI":"10.1200\/JCO.2007.12.8298"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Kridel                            R,                                Xerri                            L,                                Gelas-Dore                            B                    <i>et al.<\/i> The Prognostic Impact of CD163-Positive Macrophages in                    Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study                    Association. Clin Cancer Res. 2015; 21: 3428-3435.","DOI":"10.1158\/1078-0432.CCR-14-3253"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Stevens                            WBC,                                Mendeville                            M,                                Redd                            R                    <i>et al.<\/i> Prognostic relevance of CD163 and CD8 combined with EZH2                    and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg                    Lymphoma Biomarker Consortium. Haematologica. 2017; 102:                    1413-1423.","DOI":"10.3324\/haematol.2017.165415"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Zhang                            W,                                Huang                            Q,                                Xiao                            W                    <i>et al.<\/i> Advances in Anti-Tumor Treatments Targeting the                    CD47\/SIRP\u03b1 Axis. Front Immunol. 2020; 11: 18.","DOI":"10.3389\/fimmu.2020.00018"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Chen                            YP,                                Kim                            HJ,                                Wu                            H                    <i>et al.<\/i> SIRP\u03b1 expression delineates subsets of intratumoral                    monocyte\/macrophages with different functional and prognostic impact in                    follicular lymphoma. Blood Cancer J. 2019; 9: 84.","DOI":"10.1038\/s41408-019-0246-0"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Husson                            H,                                Freedman                            AS,                                Cardoso                            AA                    <i>et al.<\/i> CXCL13 (BCA-1) is produced by follicular lymphoma cells:                    role in the accumulation of malignant B cells. Br J Haematol. 2002; 119:                    492-495.","DOI":"10.1046\/j.1365-2141.2002.03832.x"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Lwin                            T,                                Crespo                            LA,                                Wu                            A                    <i>et al.<\/i> Lymphoma cell adhesion-induced expression of B                    cell-activating factor of the TNF family in bone marrow stromal cells protects                    non-Hodgkin\u2019s B lymphoma cells from apoptosis. Leukemia. 2009; 23:                    170-177.","DOI":"10.1038\/leu.2008.266"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Epron                            G,                                Ame-Thomas                            P, Le                                Priol                            J                    <i>et al.<\/i> Monocytes and T cells cooperate to favor normal and                    follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling. Leukemia.                    2012; 26: 139-148.","DOI":"10.1038\/leu.2011.179"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Tjin                            EPM,                                Groen                            RWJ,                                Vogelzang                            I                    <i>et al.<\/i> Functional analysis of HGF\/MET signaling and aberrant                    HGF-activator expression in diffuse large B-cell lymphoma. Blood. 2006; 107:                    760-768.","DOI":"10.1182\/blood-2005-05-1929"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Freedman                            AS,                                Munro                            JM,                                Morimoto                            C                    <i>et al.<\/i> Follicular non-Hodgkin\u2019s lymphoma cell adhesion to                    normal germinal centers and neoplastic follicles involves very late antigen-4                    and vascular cell adhesion molecule-1. Blood. 1992; 79:                    206-212.","DOI":"10.1182\/blood.V79.1.206.bloodjournal791206"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70 Petrasch                            S,                                Kosco                            M,                                Schmitz                            J,                                Wacker                            HH,                                Brittinger                            G. Follicular                    dendritic cells in non-Hodgkin-lymphoma express adhesion molecules complementary                    to ligands on neoplastic B-cells. Br J Haematol. 1992; 82:                    695-700.","DOI":"10.1111\/j.1365-2141.1992.tb06946.x"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71 Abe                            Y,                                Sakata-Yanagimoto                            M,                                Fujisawa                            M                    <i>et al.<\/i> A single-cell atlas of non-haematopoietic cells in human                    lymph nodes and lymphoma reveals a landscape of stromal remodelling. Nat Cell                    Biol. 2022; 24: 565-578.","DOI":"10.1038\/s41556-022-00866-3"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72 Gonz\u00e1lez-Gonz\u00e1lez                            L,                                Alonso                            J. Periostin: A                    Matricellular Protein With Multiple Functions in Cancer Development and                    Progression. Front Oncol. 2018; 8: 225.","DOI":"10.3389\/fonc.2018.00225"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73 An                            J,                                Du                            Y,                                Fan                            X                    <i>et al.<\/i> EGFL6 promotes breast cancer by simultaneously enhancing                    cancer cell metastasis and stimulating tumor angiogenesis. Oncogene. 2019; 38:                    2123-2134.","DOI":"10.1038\/s41388-018-0565-9"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74 Cremasco                            V,                                Astarita                            JL,                                Grauel                            AL                    <i>et al.<\/i> FAP Delineates Heterogeneous and Functionally Divergent                    Stromal Cells in Immune-Excluded Breast Tumors. Cancer Immunol Res. 2018; 6:                    1472-1485.","DOI":"10.1158\/2326-6066.CIR-18-0098"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75 Costa                            A,                                Kieffer                            Y,                                Scholer-Dahirel                            A                    <i>et al.<\/i> Fibroblast Heterogeneity and Immunosuppressive                    Environment in Human Breast Cancer. Cancer Cell. 2018; 33:                    463-479.e10.","DOI":"10.1016\/j.ccell.2018.01.011"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76 Kieffer                            Y,                                Hocine                            HR,                                Gentric                            G                    <i>et al.<\/i> Single-Cell Analysis Reveals Fibroblast Clusters Linked                    to Immunotherapy Resistance in Cancer. Cancer Discov. 2020; 10:                    1330-1351.","DOI":"10.1158\/2159-8290.CD-19-1384"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77 Yang                            ZZ,                                Grote                            DM,                                Xiu                            B                    <i>et al.<\/i> TGF-\u03b2 upregulates CD70 expression and induces exhaustion                    of effector memory T cells in B-cell non-Hodgkin\u2019s lymphoma. Leukemia. 2014; 28:                    1872-1884.","DOI":"10.1038\/leu.2014.84"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78 Al                                Sayed                            MF,                                Ruckstuhl                            CA,                                Hilmenyuk                            T                    <i>et al.<\/i> CD70 reverse signaling enhances NK cell function and                    immunosurveillance in CD27-expressing B-cell malignancies. Blood. 2017; 130:                    297-309.","DOI":"10.1182\/blood-2016-12-756585"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79 Opitz                            CA,                                Somarribas Patterson                            LF,                                Mohapatra                            SR                    <i>et al.<\/i> The therapeutic potential of targeting tryptophan                    catabolism in cancer. Br J Cancer. 2020; 122: 30-44.","DOI":"10.1038\/s41416-019-0664-6"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/3\/63_23012\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T05:06:57Z","timestamp":1696050417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/3\/63_23012\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.23012","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"23012"}}